These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6019354)

  • 21. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
    Kirti S; Dutta PK; Vaishnava H; Singh RB
    J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
    [No Abstract]   [Full Text] [Related]  

  • 22. The oral antidiabetic agents.
    Bierman EL
    Am Fam Physician; 1976 Jan; 13(1):98-104. PubMed ID: 1251792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary intake and hyperlipidemia in controlled diabetic outpatients.
    Maruhama Y; Abe R; Okuguchi F; Ohneda A
    Diabetes; 1977 Feb; 26(2):94-9. PubMed ID: 838168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult diabetic.
    Schwartz MJ; Mirsky S; Schaefer LE
    Metabolism; 1966 Sep; 15(9):808-22. PubMed ID: 5929037
    [No Abstract]   [Full Text] [Related]  

  • 29. Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM.
    Karam JH; Sanz N; Salamon E; Nolte MS
    Diabetes; 1986 Dec; 35(12):1314-20. PubMed ID: 3533680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
    Bickel M; Geisen K; Schleyerbach R
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of hypoglycemic effect of sulfonylureas by halofenate.
    Jain AK; Ryan JR; McMahon FG
    N Engl J Med; 1975 Dec; 293(25):1283-6. PubMed ID: 171574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined therapy of insulin and tolazamide decreases insulin requirement and serum triglycerides in obese patients with noninsulin-dependent diabetes mellitus.
    Kitabchi AE; Soria AG; Radparvar A; Lawson-Grant V
    Am J Med Sci; 1987 Jul; 294(1):10-4. PubMed ID: 3605188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics.
    Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS
    Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R; DALLECOSTE P
    Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of oral hypoglycemic agents on the lipid levels in non-insulin-dependent diabetes in the young.
    Jialal I; Joubert SM
    S Afr Med J; 1982 Sep; 62(11):348-9. PubMed ID: 7112299
    [No Abstract]   [Full Text] [Related]  

  • 37. The direct and indirect effects of insulin on hepatic glucose production in vivo.
    Cherrington AD; Edgerton D; Sindelar DK
    Diabetologia; 1998 Sep; 41(9):987-96. PubMed ID: 9754815
    [No Abstract]   [Full Text] [Related]  

  • 38. CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS.
    RENNIE CS; ANDERSON DO
    Can Med Assoc J; 1963 Sep; 89(13):669-71. PubMed ID: 14077815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "THE TOLBUTAMIDE TOLERANCE TEST, THE EFFECTS OF CHLOROTHIAZIDE ON GLUCOSE METABOLISM, AND THE PRESENT STATUS OF ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF DIABETES".
    MCDONALD WP
    Memphis Mid South Med J; 1963 Mar; 38():114-7. PubMed ID: 14087835
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study on the effect of phenethylbiguanide on responses to insulin, tolbutamide and glucose in diabetes mellitus].
    Czyzyk A; Lawecki J
    Diabetologia; 1966 Jun; 2(1):62-8. PubMed ID: 6005291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.